BioSpace News Archive

Confirm BioSciences, a leading developer of high-quality diagnostic testing and health and wellness solutions, today announced the addition of two key executive appointments to its global sales team, bringing to the group vast expertise across both strategic and enterprise sales in the diagnostics, drug testing and workplace screening sectors.

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced that it has executed a share exchange agreement to effect the acquisition of SAVSU Technologies, a leading developer of advanced cold chain management tools for cell and gene therapies.

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today reported financial results for the second quarter ended June 30, 2019.

OcuNexus Therapeutics, a clinical stage biotechnology company developing a first-in-class orally administered treatment for the dry form of age-related macular degeneration and diabetic retinopathy, today announced that it has strengthened its board of directors with the addition of Mr. Rajiv Shukla,

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, today reported financial results for the second quarter ended June 30, 2019

Research Bridge Partners—a not-for-profit that enhances the societal and economic returns on America’s investment in research universities by bridging mid-continent university innovators and commercialization resources nationally—announced the investment of seed capital in Novosteo, Inc.

Varian (NYSE: VAR) today announced that its executive staff will be meeting with analysts and investors at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago on Monday, September 16, 2019 at 2:00 p.m. Central Time.

TB12, the performance lifestyle brand founded by six-time Super Bowl champion Tom Brady, enhances their nutrition category with its very first line of nutritional supplements designated as NSF Certified for Sport® to help support a holistic approach to overall health and athletic performance.

Eagle Pharmaceuticals, Inc. announced its financial results for the three- and six-months ended June 30, 2019

AVEO Oncology reported financial results for the second quarter ended June 30, 2019 and provided a business update.